Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Atricure (ATRC)
NASDAQ:ATRC
Atricure (ATRC) Stock Price & Analysis
297 Followers
ATRC Stock Chart & Stats
Day’s Range$22.07 - $22.88
52-Week Range― - ―
Previous Close$23.05
Volume326.85K
Average Volume (3M)N/A
Market Cap
$1.12B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 01, 2024EPS Estimate
-$0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$51.89Price Target Upside129.50% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
Atricure News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAtriCure reported a notable increase in revenue, with a 21% rise year over year, showcasing the company's strong sales performance.
Growth PotentialAtriCure's forward-looking guidance anticipates revenue growth and profitability, reflecting confidence in its business strategy and product lineup.
Market PositionAtriCure's market leadership in left atrial appendage management is reinforced by the AtriClip's proven outcomes and substantial user base.
Bears Say
CompetitionAtriCure's stock experienced a sharp decline due to the announcement of a competing product by Medtronic.
Financial PerformanceOperating margin was down significantly, alongside a decrease in adjusted EBITDA margin.
Stock PerformanceATRC's stock experienced a significant intraday drop, which indicates volatility and investor concern.
---
Ownership Overview
11.61% Insiders
40.67% Mutual Funds
19.46% Other Institutional Investors
28.26% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ATRC FAQ
What was Atricure’s price range in the past 12 months?
Currently, no data Available
What is Atricure’s market cap?
Currently, no data Available
When is Atricure’s upcoming earnings report date?
Atricure’s upcoming earnings report date is May 01, 2024 which is in 5 days.
How were Atricure’s earnings last quarter?
Atricure released its earnings results on Feb 15, 2024. The company reported -$0.21 earnings per share for the quarter, beating the consensus estimate of -$0.225 by $0.015.
Is Atricure overvalued?
According to Wall Street analysts Atricure’s price is currently Undervalued.
Does Atricure pay dividends?
Atricure does not currently pay dividends.
What is Atricure’s EPS estimate?
Atricure’s EPS estimate is -$0.23.
How many shares outstanding does Atricure have?
Currently, no data Available
What happened to Atricure’s price movement after its last earnings report?
Atricure reported an EPS of -$0.21 in its last earnings report, beating expectations of -$0.225. Following the earnings report the stock price went down -4.355%.
Which hedge fund is a major shareholder of Atricure?
Among the largest hedge funds holding Atricure’s share is Royce & Associates LLC. It holds Atricure’s shares valued at 3M.
---
Atricure Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$51.89 (129.50% Upside)
$51.89 (129.50% Upside)
Blogger Sentiment
Bullish
ATRC Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 106.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $244.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 17.6%
Last 30 Days ▲ 8.2%
Last 30 Days ▲ 8.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.89%
12-Months-Change
Fundamentals
Return on Equity
-6.60%
Trailing 12-Months
Asset Growth
4.87%
Trailing 12-Months
Company Description
Atricure
AtriCure, Inc. engages development, manufacture and sale of devices designed primarily for the surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio Frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, Other International, and Total International. The company was founded by Michael D. Hooven on October 31, 2000 and is headquartered in West Chester, OH.
---
ATRC Earnings Call
Q4 2024
0:00 / 0:00
---
ATRC Stock 12 Months Forecast
Average Price Target
$51.89
▲(129.50% Upside)
Technical Analysis
Best Analysts Covering ATRC
1 Year
1 Year Success Rate
16/19 ratings generated profit
1 Year Average Return
+43.61%
upgraded a buy rating 3 days ago
Copying Suraj Kalia's trades and holding each position for 1 Year would result in 84.21% of your transactions generating a profit, with an average return of +43.61% per trade.
---